VRS
CGEM icon

Virginia Retirement Systems’s Cullinan Oncology CGEM Stock Holding History

Virginia Retirement Systems’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,627
Closed -$80.4K – 958
2025
Q1 		$80.4K Buy
+10,627
New +$102K ﹤0.01% 1004
2023
Q3 		$586K Sell
64,700
-100
-0.2% -$1.04K 0.01% 653
2023
Q2 		$697K Buy
64,800
+2,900
+5% +$30.8K 0.01% 638
2023
Q1 		$633K Buy
61,900
+8,300
+15% +$91.5K 0.01% 677
2022
Q4 		$565K Buy
53,600
+11,700
+28% +$142K 0.01% 796
2022
Q3 		$537K Buy
+41,900
New +$565K 0.01% 789

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Virginia Retirement Systems's CGEM Position: Q2 2025 in Review

Virginia Retirement Systems sold out of Cullinan Oncology (CGEM) in Q2 2025, closing a stake of 10,627 shares — an estimated $80.4K sold.

Virginia Retirement Systems first reported a position in CGEM in Q3 2022 and held it in 6 quarters. The position peaked at $697K in Q2 2023. 143 funds tracked by Wall St. Rank hold CGEM as of Q2 2025.

  • Virginia Retirement Systems reported no remaining Cullinan Oncology position as of Q2 2025 after selling out during the quarter.
  • Virginia Retirement Systems sold 10,627 Cullinan Oncology shares in Q2 2025, an estimated $80.4K.
  • Virginia Retirement Systems first reported a position in Cullinan Oncology in Q3 2022 and held it in 6 quarters.
  • Virginia Retirement Systems's Cullinan Oncology position peaked at $697K in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2025.

Based on Virginia Retirement Systems's 13F filing for Q2 2025, filed 29 Jul 2025.